Skip to main content

Table 4 Selected cost and effectiveness estimates

From: The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women

 

Indirect HIV costs included

Indirect HIV costs excluded

Item estimated

Complete intervention

Condom use skills component of intervention

Complete intervention

Condom use skills component of intervention

Cost of intervention

$121,296

$51,338

$121,296

$51,338

Expected number of HIV cases averted

0.2195

0.1756

0.2195

0.1756

Expected HIV costs averted

$73,960

$59,168

$42,796

$34,237

Net cost (intervention costs – HIV costs averted)

$47,336

-$7,830

$78,500

$17,101

Average cost per HIV case averted

$215,690

cost-saving

$357,690

$97,404

Incremental cost per HIV case averted

$1,256,831

-

$1,398,831

-

Average cost per QALY

na

na

$31,851

$8,674

Incremental cost per QALY

na

na

$124,562

-

  1. Notes: Costs are expressed in 1996 US$. The average cost per case averted (the average cost-effectiveness ratio) compares each option to the alternative of no intervention, which has a program cost of $0 and results in 2.54 new HIV infections. The incremental cost-effectiveness ratios compare the complete intervention to the option of offering only the condom use skills component. "Cost-saving" indicates that the averted HIV costs exceeded the cost of the intervention. We did not calculate cost-effectiveness ratios using QALYs when indirect HIV costs were included in the analysis, as the QALY measures to some degree incorporate these indirect costs.